Buscar
Mediwound Ltd
MDWDAñadir a la lista de seguimiento
13.570USD
+0.010+0.07%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
174.41MCap. mercado
PérdidaP/E TTM
Más Datos de Mediwound Ltd Compañía
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.
Perfil de Mediwound Ltd
Símbolo de cotizaciónMDWD
Nombre de la empresaMediwound Ltd
Fecha de salida a bolsaMar 20, 2014
Director ejecutivoGonen (Ofer)
Número de empleados111
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 20
Dirección42 Hayarkon Street
CiudadYAVNE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal8122745
Teléfono972779714100
Sitio Webhttps://www.mediwound.com/
Símbolo de cotizaciónMDWD
Fecha de salida a bolsaMar 20, 2014
Director ejecutivoGonen (Ofer)
Ejecutivos de Mediwound Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ofer Gonen
Mr. Ofer Gonen
Chief Executive Officer
Chief Executive Officer
275.42K
+33.88%
Mr. Ofer Gonen
Mr. Ofer Gonen
Chief Executive Officer
Chief Executive Officer
275.42K
+33.88%
Mr. Yaron Meyer
Mr. Yaron Meyer
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
8.57K
--
Mr. Yaron Meyer
Mr. Yaron Meyer
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
8.57K
--
Dr. Vickie R. Driver, M.D.
Dr. Vickie R. Driver, M.D.
Independent Director
Independent Director
--
--
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Independent Director
Independent Director
--
--
Dr. Ety Klinger, Ph.D.
Dr. Ety Klinger, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. David Fox
Mr. David Fox
Independent Director
Independent Director
--
--
Mr. Shmuel (Milky) Rubinstein
Mr. Shmuel (Milky) Rubinstein
Independent Director
Independent Director
--
--
Dr. Shmulik Hess
Dr. Shmulik Hess
Chief Operating Officer, Chief Commercial Officer
Chief Operating Officer, Chief Commercial Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ofer Gonen
Mr. Ofer Gonen
Chief Executive Officer
Chief Executive Officer
275.42K
+33.88%
Mr. Ofer Gonen
Mr. Ofer Gonen
Chief Executive Officer
Chief Executive Officer
275.42K
+33.88%
Mr. Yaron Meyer
Mr. Yaron Meyer
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
8.57K
--
Mr. Yaron Meyer
Mr. Yaron Meyer
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
8.57K
--
Dr. Vickie R. Driver, M.D.
Dr. Vickie R. Driver, M.D.
Independent Director
Independent Director
--
--
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Mediwound Ltd?
Los cinco principales accionistas de Mediwound Ltd son: Mr. Ofer Gonen
¿Cuántas instituciones poseen acciones de Mediwound Ltd (MDWD)?
A fecha de 2026Q1, 165 instituciones poseen acciones de Mediwound Ltd, con un valor de mercado combinado de aproximadamente 7.42M, lo que representa el 57.77% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 298423.00.